InsiderTrades

Form 4 for CRMD CorMedix Inc.

Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-17 · accession 0001213900-21-060724 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2021-11-19 2021-11-17 CRMD David Matthew T CFO, Interim CEO P - Purchase $5.07 +1,000 2,150 +87% +$5,070

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-17 P A 1,000 $5.07 2,150 D — —